JP2011523347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011523347A5 JP2011523347A5 JP2010544350A JP2010544350A JP2011523347A5 JP 2011523347 A5 JP2011523347 A5 JP 2011523347A5 JP 2010544350 A JP2010544350 A JP 2010544350A JP 2010544350 A JP2010544350 A JP 2010544350A JP 2011523347 A5 JP2011523347 A5 JP 2011523347A5
- Authority
- JP
- Japan
- Prior art keywords
- alphavirus
- attenuated
- subgenomic
- virus
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 12
- 230000035772 mutation Effects 0.000 claims description 10
- 241000255925 Diptera Species 0.000 claims description 8
- 101710121417 Envelope glycoprotein Proteins 0.000 claims description 7
- 210000000234 capsid Anatomy 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 230000001419 dependent effect Effects 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 108090000565 Capsid Proteins Proteins 0.000 claims description 2
- 102100023321 Ceruloplasmin Human genes 0.000 claims description 2
- 241000710929 Alphavirus Species 0.000 claims 33
- 230000002238 attenuated effect Effects 0.000 claims 20
- 108091026890 Coding region Proteins 0.000 claims 4
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 101710159910 Movement protein Proteins 0.000 claims 3
- 101710144117 Non-structural protein 4 Proteins 0.000 claims 3
- 241000710959 Venezuelan equine encephalitis virus Species 0.000 claims 3
- 108020005345 3' Untranslated Regions Proteins 0.000 claims 2
- 108020003589 5' Untranslated Regions Proteins 0.000 claims 2
- 101800000980 Protease nsP2 Proteins 0.000 claims 2
- 101800001758 RNA-directed RNA polymerase nsP4 Proteins 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000003044 adaptive effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 241001502567 Chikungunya virus Species 0.000 claims 1
- 241000710945 Eastern equine encephalitis virus Species 0.000 claims 1
- 241000710188 Encephalomyocarditis virus Species 0.000 claims 1
- 241000283073 Equus caballus Species 0.000 claims 1
- 101710144128 Non-structural protein 2 Proteins 0.000 claims 1
- 101710199667 Nuclear export protein Proteins 0.000 claims 1
- 102100021696 Syncytin-1 Human genes 0.000 claims 1
- 241000710951 Western equine encephalitis virus Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 230000017610 release of virus from host Effects 0.000 claims 1
- 230000029812 viral genome replication Effects 0.000 claims 1
- 230000005540 biological transmission Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 241000256118 Aedes aegypti Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6222908P | 2008-01-24 | 2008-01-24 | |
| US61/062,229 | 2008-01-24 | ||
| PCT/US2009/000458 WO2009131604A2 (en) | 2008-01-24 | 2009-01-23 | Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011523347A JP2011523347A (ja) | 2011-08-11 |
| JP2011523347A5 true JP2011523347A5 (OSRAM) | 2014-06-19 |
| JP5758632B2 JP5758632B2 (ja) | 2015-08-05 |
Family
ID=41217313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010544350A Expired - Fee Related JP5758632B2 (ja) | 2008-01-24 | 2009-01-23 | 蚊において複製不可能な弱毒化組み換えアルファウイルス属及びそれらの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8426188B2 (OSRAM) |
| EP (2) | EP3085787B1 (OSRAM) |
| JP (1) | JP5758632B2 (OSRAM) |
| KR (2) | KR101913790B1 (OSRAM) |
| CN (1) | CN102083986B (OSRAM) |
| AU (1) | AU2009238667A1 (OSRAM) |
| CA (2) | CA2713165C (OSRAM) |
| CO (1) | CO6290702A2 (OSRAM) |
| IL (2) | IL207167A (OSRAM) |
| MX (3) | MX367792B (OSRAM) |
| MY (1) | MY178870A (OSRAM) |
| NZ (2) | NZ603790A (OSRAM) |
| SG (2) | SG187513A1 (OSRAM) |
| WO (1) | WO2009131604A2 (OSRAM) |
| ZA (1) | ZA201005943B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2183368T3 (pl) * | 2007-06-21 | 2016-12-30 | Kasety bez promotora do ekspresji alfawirusowych białek strukturalnych | |
| WO2009131604A2 (en) | 2008-01-24 | 2009-10-29 | The Board Of Regents Of The University Of Texas System | Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| US8961995B2 (en) | 2012-09-20 | 2015-02-24 | Uab Research Foundation | Methods and compositions for alphavirus replicons |
| BR112015006840A2 (pt) | 2012-09-27 | 2017-11-21 | Res Found Dev | vírus chikungunya atenuado |
| MX361342B (es) | 2013-03-14 | 2018-12-04 | Takeda Vaccines Inc | Composiciones y metodos para formulaciones de alfavirus vivos atenuados. |
| MX2018011839A (es) * | 2016-03-31 | 2019-05-23 | Takeda Vaccines Inc | Constructos de alfavirus vivo atenuado y metodos y usos de los mismos. |
| PH12018502460B1 (en) * | 2016-05-27 | 2023-11-08 | Univ Griffith | Arthrogenic alphavirus vaccine |
| MX2019013259A (es) | 2017-05-08 | 2020-01-13 | Gritstone Oncology Inc | Vectores de neoantigeno de alfavirus. |
| WO2020028749A1 (en) * | 2018-08-03 | 2020-02-06 | Uab Research Foundation | Methods and compositions for alphavirus vaccine |
| CN109536464B (zh) * | 2018-12-10 | 2022-06-10 | 中国科学院武汉病毒研究所 | 一种缺失衣壳蛋白基因的基孔肯雅病毒感染性克隆及构建方法和在制备减毒疫苗中的应用 |
| AU2020282369A1 (en) | 2019-05-30 | 2022-01-20 | Seattle Project Corp. | Modified adenoviruses |
| AU2020417800A1 (en) | 2019-12-31 | 2022-07-14 | Elixirgen Therapeutics, Inc. | Temperature-based transient delivery of nucleic acids and proteins to cells and tissues |
| CA3187258A1 (en) | 2020-08-06 | 2022-02-10 | Karin Jooss | Multiepitope vaccine cassettes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451592B1 (en) * | 1996-04-05 | 2002-09-17 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| CA2327189A1 (en) * | 2000-12-21 | 2002-06-21 | The Minister Of National Defence | Novel dna-based vaccine against the encephalitis alphaviruses |
| JP5016305B2 (ja) * | 2003-03-20 | 2012-09-05 | アルファヴァックス，インコーポレイテッド | 改良されたアルファウイルスレプリコンおよびヘルパー構築物 |
| US7603447B2 (en) | 2004-07-30 | 2009-10-13 | Research In Motion Limited | Method and system for coordinating device setting between a communications client and its host device |
| US7332322B2 (en) * | 2004-09-14 | 2008-02-19 | Ilya Frolov | Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof |
| CA2579507C (en) | 2006-03-15 | 2017-06-13 | Institut Pasteur | Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| WO2009131604A2 (en) * | 2008-01-24 | 2009-10-29 | The Board Of Regents Of The University Of Texas System | Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
-
2009
- 2009-01-23 WO PCT/US2009/000458 patent/WO2009131604A2/en not_active Ceased
- 2009-01-23 KR KR1020167029024A patent/KR101913790B1/ko not_active Expired - Fee Related
- 2009-01-23 MX MX2014010258A patent/MX367792B/es unknown
- 2009-01-23 MX MX2019010530A patent/MX378503B/es unknown
- 2009-01-23 KR KR1020107018777A patent/KR101668849B1/ko not_active Expired - Fee Related
- 2009-01-23 EP EP16000617.7A patent/EP3085787B1/en not_active Not-in-force
- 2009-01-23 AU AU2009238667A patent/AU2009238667A1/en not_active Abandoned
- 2009-01-23 CA CA2713165A patent/CA2713165C/en not_active Expired - Fee Related
- 2009-01-23 NZ NZ603790A patent/NZ603790A/en not_active IP Right Cessation
- 2009-01-23 EP EP09735287.6A patent/EP2250269B1/en not_active Not-in-force
- 2009-01-23 SG SG2013005624A patent/SG187513A1/en unknown
- 2009-01-23 MX MX2010007989A patent/MX2010007989A/es active IP Right Grant
- 2009-01-23 MY MYPI2010003463A patent/MY178870A/en unknown
- 2009-01-23 CN CN200980110510.1A patent/CN102083986B/zh not_active Expired - Fee Related
- 2009-01-23 SG SG10201606111XA patent/SG10201606111XA/en unknown
- 2009-01-23 JP JP2010544350A patent/JP5758632B2/ja not_active Expired - Fee Related
- 2009-01-23 CA CA2910235A patent/CA2910235C/en not_active Expired - Fee Related
- 2009-01-23 NZ NZ587502A patent/NZ587502A/xx not_active IP Right Cessation
-
2010
- 2010-07-22 IL IL207167A patent/IL207167A/en active IP Right Grant
- 2010-07-23 US US12/804,535 patent/US8426188B2/en active Active
- 2010-08-20 CO CO10102866A patent/CO6290702A2/es active IP Right Grant
- 2010-08-20 ZA ZA2010/05943A patent/ZA201005943B/en unknown
-
2013
- 2013-04-03 US US13/855,960 patent/US9580690B2/en active Active
-
2014
- 2014-04-09 IL IL232032A patent/IL232032A0/en unknown
-
2017
- 2017-02-27 US US15/443,364 patent/US10533186B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011523347A5 (OSRAM) | ||
| US12331076B2 (en) | Alphavirus-based replicons for administration of biotherapeutics | |
| Sun et al. | Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease | |
| US20230126773A1 (en) | Recombinant virus replicon systems and uses thereof | |
| Gardner et al. | Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis | |
| CN1989250B (zh) | Tc-83衍生的甲病毒属载体、颗粒和方法 | |
| JP2017522907A5 (OSRAM) | ||
| JP5758632B2 (ja) | 蚊において複製不可能な弱毒化組み換えアルファウイルス属及びそれらの使用 | |
| Gorchakov et al. | Selection of functional 5′ cis-acting elements promoting efficient Sindbis virus genome replication | |
| JP2021511318A (ja) | 組換えレプリコン系を使用する免疫応答の誘導および増強 | |
| Wang et al. | Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate | |
| ZA200007403B (en) | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals. | |
| TWI769467B (zh) | 用作b型肝炎病毒(hbv)疫苗之自我複製rna分子及其用途 | |
| Flick et al. | Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments | |
| JP2019509750A5 (OSRAM) | ||
| de Haan et al. | Coronaviruses as vectors: stability of foreign gene expression | |
| JP2004501646A5 (OSRAM) | ||
| JP2017515509A (ja) | ワクチン用途のための高力価ウイルス様ベシクルの進化の方法 | |
| CN111744000A (zh) | 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用 | |
| Urban et al. | Major capsid protein synthesis from the genomic RNA of feline calicivirus | |
| Kim et al. | Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype | |
| Strauss et al. | Molecular genetic evidence that the hydrophobic anchors of glycoproteins E2 and E1 interact during assembly of alphaviruses | |
| Harouaka et al. | Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid protein | |
| EP1029069B1 (en) | Alphavirus vectors | |
| WO2005093070A1 (ja) | 組み換えヘルペスウイルス及びその利用 |